Chemours (CC)
(Delayed Data from NYSE)
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Zacks News
4 Momentum Picks to Fetch You Profits Fast
by Zacks Equity Research
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include SLCA, CC and CGNX.
Nucor (NUE) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Nucor Corporation (NUE) is set to release first-quarter 2017 results ahead of the bell on Apr 20.
Pacific Biosciences (PACB): What Awaits in Q1 Earnings?
by Zacks Equity Research
Pacific Biosciences of California Inc. (PACB) is scheduled to report first-quarter 2017 results on Apr 20.
Will Intuitive Surgical (ISRG) Surprise in Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) is scheduled to report first-quarter 2017 results after the closing bell on Apr 18.
Will Quest Diagnostics (DGX) Pull a Surprise in Q1 Earnings?
by Zacks Equity Research
Quest Diagnostics Inc. (DGX) is scheduled to report first-quarter 2017 earnings results before the opening bell on Apr 20.
Will Abbott Lab (ABT) Surprise Estimates in Q1 Earnings?
by Zacks Equity Research
Abbott Laboratories (ABT) is scheduled to report first-quarter 2017 results before the opening bell on Apr 19.
Zacks.com featured highlights: Chemours, Leucadia National, Triton International and United States Steel
by Zacks Equity Research
Zacks.com featured highlights: Chemours, Leucadia National, Triton International and United States Steel
4 Cheap PEG Stocks for Value Seeking Investors
by Zacks Equity Research
To investors looking to escape value traps, Warren Buffett advises to focus on the earnings growth potential of a stock.
American Vanguard (AVD) Inks Crop Protection Assets Deal
by Zacks Equity Research
American Vanguard Corporation (AVD) declared that itssubsidiary, AMVAC Chemical Corporation has signed an agreement to acquire specific U.S. assets relating to the three crop protection product from subsidiaries of Adama Agricultural Solutions Ltd.
Zacks.com featured highlights: Chemours, Micron Technology, John Bean Technologies, Children's Place and Boise Cascade
by Zacks Equity Research
Zacks.com featured highlights: Chemours, Micron Technology, John Bean Technologies, Children's Place and Boise Cascade
Iamgold Announces Redemption of Senior Notes Due in 2020
by Zacks Equity Research
Iamgold Corporation (IAG) has declared that it has completed the early redemption of $489 million of outstanding 6.75% Senior Notes due in Oct 2020.
5 Top Ranked Stocks with Upgraded Broker Ratings to Buy
by Zacks Equity Research
When a broker upgrades a stock, you can certainly rely on their judgment.
The Zacks Analyst Blog Highlights: Applied Optoelectronics, Chemours, Ultra Clean Holdings, Triton International and ADVA Optical Networking SE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Applied Optoelectronics, Chemours, Ultra Clean Holdings, Triton International and ADVA Optical Networking SE
Looking for a Top Momentum Stock? 3 Reasons Why Chemours (CC) is a Great Choice
by Zacks Equity Research
Chemours (CC) is a solid momentum stock that has a favorable Zacks Rank and is seeing solid earnings estimate revisions.
Top Ranked Momentum Stocks to Buy for April 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 3rd:
Mosaic Declares Production Disruption at Esterhazy Mine
by Zacks Equity Research
The Mosaic Company (MOS) recently announced a production outage at its Esterhazy K2 potash mine in Saskatchewan. This incident is likely to reduce production by 200,000 to 300,000 tons.
Can The Chemours Company (CC) Stock Continue to Grow Earnings?
by Zacks Equity Research
The Chemours Company (CC) looks like an exciting pick for investors as it is poised for strong future growth.
Can The Uptrend Continue for Chemours (CC)?
by Zacks Equity Research
Investors certainly have to be happy with Chemours Co (CC) and its short term performance
Ride the Momentum with These 4 Hot Stocks
by Zacks Equity Research
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include: X, AMAT and CC.
Why The Chemours Company (CC) Isn't Done Growing Earnings Yet
by Zacks Equity Research
The Chemours Company (CC) looks like an exciting pick for investors as it is poised for strong future growth.
Chemours (CC) Shares March Higher, Can It Continue?
by Zacks Equity Research
Chemours Company (CC) has been on the move lately as the stock has risen by 30.6% in the past four weeks, and it is currently trading well above its 20-Day SMA
Top Ranked Growth Stocks to Buy for January 12th
by Zacks Equity Research
Here are four stocks with Zacks Rank#1 (Strong Buy) and strong growth characteristics for investors to consider today, January 12th:
The Zacks Analyst Blog Highlights: Chemours, Teck Resources, Applied Materials and Finisar
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chemours, Teck Resources, Applied Materials and Finisar
Top Ranked Value Stocks to Buy for January 10th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, January 10th:
Top Ranked Value Stocks to Buy for January 9th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, January 9th: